Here are relevant reports on : chemical-reagents-market
-
Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020
The global platelet aggregation devices market is poised to reach a value of 342.4 Million by 2020, growing at a CAGR of 21.0% from 2015 to 2020. Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fueling the growth of the global platelet aggregation devices market. However, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors restraining the growth of this market.
- Published: August 2015
- Price: $ 4950
- TOC Available:
-
Sterility Testing Market by Product (Kits & Reagents, Instrument, Services), Test (Membrane Filtration, Direct Inoculation), Application (Pharma, Biological Manufacturing, Medical Device Manufacturing), End User (Pharma, Biotech) & Region - Global Forecasts to 2028
The global sterility testing market, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$1.9 billion by the end of the period. Factors such as expanding pharmaceutical & biotechnology production capacities, increasing development of novel biopharmaceutical products, and rising investments in life sciences research are expected to drive market growth.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031
The global in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing at a CAGR of 10.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030
The global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031
The UK next-generation sequencing market, valued at USD 0.73 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 14.8% from 2026 to 2031, culminating in a forecasted valuation of USD 1.59 billion by the end of the period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecasts to 2023
The global creatinine measurement market is projected to reach USD 564.5 Million by 2023, at a CAGR of 8.4%. The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives. The creatinine measurement market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).
- Published: June 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
